Target deconvolution strategies in drug discovery
暂无分享,去创建一个
[1] P. Cuatrecasas. Affinity chromatography and purification of the insulin receptor of liver cell membranes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[2] S. Shaltiel. [9] Hydrophobic chromatography , 1974 .
[3] S. Shaltiel. Hydrophobic chromatography. , 1974, Methods in enzymology.
[4] S. Shaltiel. [3] Hydrophobic chromatography , 1984 .
[5] G. P. Smith,et al. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.
[6] P. Laing,et al. Luminescent visualization of antigens on blots. , 1986, Journal of immunological methods.
[7] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[8] Nolan H. Sigal,et al. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.
[9] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[10] S. Schreiber,et al. A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.
[11] W. Dower,et al. An in vitro polysome display system for identifying ligands from very large peptide libraries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] Y. Clonis,et al. The affinity technology in downstream processing. , 1994, Journal of biotechnology.
[13] S. Schreiber,et al. A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.
[14] E J Licitra,et al. A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Ampe,et al. A Phage Display Technique for a Fast, Sensitive, and Systematic Investigation of Protein–Protein Interactions , 1997, Journal of protein chemistry.
[16] S H Kim,et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.
[17] J. Yates. Mass spectrometry and the age of the proteome. , 1998, Journal of mass spectrometry : JMS.
[18] Georg C. Terstappen,et al. High Throughput Scintillation Proximity Assay for the Identification of FKBP-12 Ligands , 1999, Journal of biomolecular screening.
[19] D. Austin,et al. Display cloning: functional identification of natural product receptors using cDNA-phage display. , 1999, Chemistry & biology.
[20] H. Handa,et al. High-performance affinity beads for identifying drug receptors , 2000, Nature Biotechnology.
[21] J Mottram,et al. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. , 2000, Chemistry & biology.
[22] S. Schreiber,et al. Printing proteins as microarrays for high-throughput function determination. , 2000, Science.
[23] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[24] D. Sabatini,et al. Microarrays of cells expressing defined cDNAs , 2001, Nature.
[25] M. Wright,et al. In Vitro Selection and Characterization of Bcl-XL-binding Proteins from a Mix of Tissue-specific mRNA Display Libraries* , 2001, The Journal of Biological Chemistry.
[26] Timothy A J Haystead,et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome. , 2002, Molecular pharmacology.
[27] B. Kreider,et al. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. , 2002, Chemistry & biology.
[28] J. Kuriyan,et al. Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. , 2002, Cancer research.
[29] John Kuriyan,et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). , 2001, Cancer research.
[30] K. Fitzgerald,et al. Model Organisms in Drug Discovery , 2003 .
[31] R. Strausberg,et al. From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.
[32] A. Jungbauer,et al. Directed immobilization of peptide ligands to accessible pore sites by conjugation with a placeholder molecule. , 2003, Analytical chemistry.
[33] M. Cotten,et al. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Snyder,et al. Protein chip technology. , 2003, Current opinion in chemical biology.
[35] Michael N. Hall,et al. TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.
[36] Yoshiya Oda,et al. Quantitative chemical proteomics for identifying candidate drug targets. , 2003, Analytical chemistry.
[37] T. Mayer,et al. Chemical genetics: tailoring tools for cell biology. , 2003, Trends in cell biology.
[38] Keiryn L. Bennett,et al. Analysis of large-scale MS data sets: the dramas and the delights , 2004 .
[39] E. Brown,et al. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. , 2004, Chemistry & biology.
[40] C. Nguyên,et al. A small molecule inhibitor of -cateninCREB-binding protein transcription , 2004 .
[41] Dalia Cohen,et al. Functional genomics to new drug targets , 2004, Nature Reviews Drug Discovery.
[42] Michael I. Jordan,et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Lander,et al. Finishing the euchromatic sequence of the human genome , 2004 .
[44] Janet M Thornton,et al. Ligand selectivity and competition between enzymes in silico , 2004, Nature Biotechnology.
[45] T. Terada,et al. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. , 2004, Bioorganic & medicinal chemistry.
[46] E. Aronica,et al. Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.
[47] J. Bonfield,et al. Finishing the euchromatic sequence of the human genome , 2004, Nature.
[48] Hong Ma,et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] Paul A Clemons,et al. Complex phenotypic assays in high-throughput screening. , 2004, Current opinion in chemical biology.
[50] Sebastian Meier-Ewert,et al. A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors. , 2004, Chemistry & biology.
[51] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[52] S. Haggarty,et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] So-Jung Park,et al. A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function. , 2004, Chemistry & biology.
[54] Peter G Schultz,et al. A genome-wide overexpression screen in yeast for small-molecule target identification. , 2005, Chemistry & biology.
[55] E. Butcher. Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.
[56] F. Sams-Dodd. Target-based drug discovery: is something wrong? , 2005, Drug discovery today.
[57] Andreas Kremer,et al. A Bioinformatics Perspective on Proteomics: Data Storage, Analysis, and Integration , 2005, Bioscience reports.
[58] Walter Sneader,et al. Drug Discovery (The History) , 2005 .
[59] Lin Tang,et al. Roscovitine Targets, Protein Kinases and Pyridoxal Kinase*[boxs] , 2005, Journal of Biological Chemistry.
[60] Young-Tae Chang,et al. Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. , 2005, Chemistry & biology.
[61] A. Manolis,et al. Rethinking target discovery in polygenic diseases. , 2006, Current topics in medicinal chemistry.
[62] Eugene W Gerner,et al. Pharmacogenomics of the Polyamine Analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl] eicosane Tetrahydrochloride, CGC-11093, in the Colon Adenocarcinoma Cell Line HCT1161 , 2006, Technology in cancer research & treatment.
[63] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[64] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[65] K. Yeow,et al. Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.
[66] Jan Tavernier,et al. MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells. , 2006, Chemistry & biology.
[67] A. Tanaka,et al. A versatile method of identifying specific binding proteins on affinity resins. , 2006, Analytical biochemistry.
[68] M. Kirschner,et al. Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components. , 2006, Chemistry & biology.
[69] P. Schultz,et al. Small-molecule synergist of the Wnt/β-catenin signaling pathway , 2007, Proceedings of the National Academy of Sciences.
[70] B. Stockwell,et al. Chemical genetic approaches to probing cell death. , 2007, Current opinion in chemical biology.
[71] Sean Ekins,et al. Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.
[72] A. Sickmann,et al. Protein identification using mass spectrometry: a method overview. , 2007, EXS.
[73] G. Jiang,et al. Preparation of a biochip on porous silicon and application for label-free detection of small molecule-protein interactions. , 2007, Rapid communications in mass spectrometry : RCM.
[74] L. Meijer,et al. Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography , 2007, Biotechnology journal.
[75] M. Uesugi,et al. Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin. , 2007, Journal of the American Chemical Society.
[76] Eduardo Gonzalez-Couto,et al. Huntington's disease: from experimental results to interaction networks, patho-pathway construction and disease hypothesis , 2007, BMC Systems Biology.
[77] A. Tanaka. [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[78] Hans Clevers,et al. Mining the Wnt pathway for cancer therapeutics , 2007, Nature Reviews Drug Discovery.
[79] Xiaodong Wang,et al. Diazonamide toxins reveal an unexpected function for ornithine δ-amino transferase in mitotic cell division , 2007, Proceedings of the National Academy of Sciences.
[80] Lennart Martens,et al. Annotating the human proteome: beyond establishing a parts list. , 2007, Biochimica et biophysica acta.